Exploring the molecular mechanism of Epimedium for the treatment of ankylosing spondylitis based on network pharmacology, molecular docking, and molecular dynamics simulations-Reference-Cited by-同舟云学术

Exploring the molecular mechanism of Epimedium for the treatment of ankylosing spondylitis based on network pharmacology, molecular docking, and molecular dynamics simulations

Published:2024-05-11 Issue: Volume: Page:
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Wang Xiangjin,Wu Lijiao,Yu Maobin,Wang Hao,He Langyu,Hu Yilang,Li Zhaosen,Zheng Yuqin,Peng Bo

Funder

The Department of Science and Technology of Sichuan Province, China

The National Famous Chinese Medicine Experts Inheritance Workshop Construction Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11030-024-10877-x.pdf

Reference80 articles.

1. Kim SH, Lee SH (2023) Updates on ankylosing spondylitis: pathogenesis and therapeutic agents. J Rheum Dis 30(4):220–233

2. Bautista-Molano W, Fernández-Ávila DG, Brance ML, Ávila Pedretti MG, Burgos-Vargas R, Corbacho I et al (2023) Pan American league of associations for rheumatology recommendations for the management of axial spondyloarthritis. Nat Rev Rheumatol 19(11):724–737

3. Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS et al (2016) American college of rheumatology/spondylitis association of America/spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol 68(2):282–298

4. Stolwijk C, van Onna M, Boonen A, van Tubergen A (2016) Global prevalence of spondyloarthritis: a systematic review and Meta-regression analysis. Arthritis Care Res 68(9):1320–1331

5. Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X et al (2019) Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res 7:22